Home / Inspections / 1089056

FDA Inspection 1089056 — Mid-America Transplant Services

Mid-America Transplant Services — FEI 3001238381

The FDA completed an inspection of Mid-America Transplant Services on April 19, 2019 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 19, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Saint Louis, MO (United States)

Facility

Other inspections at this facility

  • 1247285 (NAI Fri Aug 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 997610 (NAI Wed Jan 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 901726 (NAI Thu Oct 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 841595 (NAI Thu Jul 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 633300 (NAI Mon Nov 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources